Pancreatic β-Cell Membrane Fluidity and Toxicity Induced by Human Islet Amyloid Polypeptide Species

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pilkington, Emily H ^a   Gurzov, Esteban N ^b,c   Kakinen, Aleksandr ^a   Litwak, Sara A ^b   Stanley, William J ^b,c   Davis, Thomas P ^a,d   Ke, Pu Chun ^a  

^a MONASH UNIVERSITY   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; REACTIVE OXYGEN METABOLITE;

CELL LINE; CELL MEMBRANE; CELL SURVIVAL; DRUG EFFECTS; HUMAN; MEMBRANE FLUIDITY; METABOLISM; PANCREAS ISLET BETA CELL;

CELL LINE; CELL MEMBRANE; CELL SURVIVAL; HUMANS; INSULIN-SECRETING CELLS; ISLET AMYLOID POLYPEPTIDE; MEMBRANE FLUIDITY; REACTIVE OXYGEN SPECIES;

EID: 84958581843     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21274     Document Type: Article

References (56)

1. Mendis, S. Global status report on noncommunicable diseases 2014 (World Health Organisation, Geneva, 2014).
2. Guariguata, L. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103, 137-149 (2014).
3. Mathers, C. D., Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, 2011-2030 (2006).
4. Leahy, J. L. Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res. 36, 197-209 (2005).
5. Kahn, S. E., Zraika, S., Utzschneider, K. M., Hull, R. L. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 52, 1003-1012 (2009).
6. Kamata, K. et al. Islet amyloid with macrophage migration correlates with augmented-cell deficits in type 2 diabetic patients. Amyloid 21, 191-201 (2014).
7. Jurgens, C. A. et al.-cell loss and-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am. J. Pathol. 178, 2632-2640 (2011).
8. Lorenzo, A., Razzaboni, B., Weir, G. C., Yankner, B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756-760 (1994).
9. Kayed, R. et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366 (2004).
10. Meier, J. J. et al. Inhibition of human IAPP fibril formation does not prevent-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am. J. Physiol. Endocrinol. Metabol. 291, E1317-E1324 (2006).
11. Ritzel, R. A., Meier, J. J., Lin, C.-Y., Veldhuis, J. D., Butler, P. C. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 56, 65-71 (2007).
12. Schubert, D. et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92, 1989-1993 (1995).
13. Scherbaum, W. A. The role of amylin in the physiology of glycemic control. Exp. Clin. Endocrinol. Diabetes 106, 97-102 (1998).
14. Kahn, S. E. The importance of the-cell in the pathogenesis of type 2 diabetes mellitus. Am. J. Med. 108, 2S-8S (2000).
15. Westermark, P., Li, Z.-C., Westermark, G. T., Leckström, A., Steiner, D. F. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 379, 203-206 (1996).
16. Jaikaran, E. T. A. S., Nilsson, M. R., Clark, A. Pancreatic-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation. Biochem. J. 377, 709-716 (2004).
17. Brender, J. R. et al. Role of zinc in human islet amyloid polypeptide aggregation. J. Am. Chem. Soc. 132, 8973-8983 (2010).
18. Westermark, P., Andersson, A., Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795-826 (2011).
19. Moreno-Gonzalez, I., Soto, C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin. Cell Dev. Biol. 22, 482-487 (2011).
20. Zraika, S. et al. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence Diabetologia 53, 1046-1056 (2010).
21. Knowles, T. P. J., Vendruscolo, M., Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 15, 384-396 (2014).
22. Pillay, K., Govender, P. Amylin uncovered: a review on the polypeptide responsible for type II diabetes. BioMed Res. Int. 2013, 826706 (2013).
23. Sakagashira, S. et al. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am. J. Pathol. 157, 2101-2109 (2000).
24. Seino, S., The Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus. S20G mutation of the amylin gene is associated with type II diabetes in Japanese. Diabetologia 44, 906-909 (2001).
25. Kawahara, M., Kuroda, Y., Arispe, N., Rojas, E. Alzheimer's-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077-14083 (2000).
26. Mirzabekov, T. A., Lin, M.-C., Kagan, B. L. Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271, 1988-1992 (1996).
27. Sparr, E. et al. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 577, 117-120 (2004).
28. Engel, M. F. M. et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc. Natl. Acad. Sci. USA 105, 6033-6038 (2008).
29. Meng, F., Marek, P., Potter, K. J., Verchere, C. B., Raleigh, D. P. Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit thioflavin-T interactions: implications for mechanistic studies of-cell death. Biochemistry 47, 6016-6024 (2008).
30. Govindan, P. et al. Stabilizing off-pathway oligomers by polyphenol nanoassemblies for IAPP aggregation inhibition. Sci. Rep. 6, 19463 (2016).
31. Mishra, R., Sellin, D., Radovan, D., Gohlke, A., Winter, R. Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chem Bio Chem 10, 445-449 (2009).
32. Tu, L.-H. et al. Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions. Biochemistry 54, 666-676 (2015).
33. Owen, D. M., Rentero, C., Magenau, A., Abu-Siniyeh, A., Gaus, K. Quantitative imaging of membrane lipid order in cells and organisms. Nat. Protoc. 7, 24-35 (2011).
34. Owen, D. M., Williamson, D. J., Magenau, A., Gaus, K. Sub-resolution lipid domains exist in the plasma membrane and regulate protein diffusion and distribution. Nat. Comm. 3, doi: 10.1038/ncomms2273 (2012).
35. Wang, B., Zhang, L., Bae, S. C., Granick, S. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc. Natl. Acad. Sci. USA 105, 18171-18175 (2008).
36. Sanchez, S. A., Tricerri, M. A., Gratton, E. Laurdan generalized polarization fluctuations measures membrane packing microheterogeneity in vivo. Proc. Natl. Acad. Sci. USA 109, 7314-7319 (2012).
37. Chen, R., Huang, G., Ke, P. C. Calcium-enhanced exocytosis of gold nanoparticles. Appl. Phys. Lett. 97, 093706 (2010).
38. Lorizate, M. et al. Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. J. Biol. Chem. 284, 22238-22247 (2009).
39. Proszynski, T. J., Klemm, R., Bagnat, M., Gaus, K., Simons, K. Plasma membrane polarization during mating in yeast cells. J. Cell Biol. 173, 861-866 (2006).
40. Sharadrao, P. Amylin Structure, Aggregation and pancreatic cell toxicity. Doctoral Dissertations, University of Connecticut, Paper 833 (2015).
41. vandenAkker, C. C. et al. Nanoscale heterogeneity of the molecular structure of individual hIAPP amyloid fibrils revealed with tipenhanced Raman spectroscopy. Small 11, 4131-4139 (2015).
42. Parasassi, T., De Statio, G., d'Ubaldo, A., Gratton, E. Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence. Biophys. J. 57, 1179-1186 (1990).
43. Lutz, T. A., Meyer, U. Amylin at the interface between metabolic and neurodegenerative disorders. Front. Neurosci. 9, doi: 10.3389/fnins.2015.00216 (2015).
44. Jackson, K. et al. Amylin deposition in the brain: a second amyloid in Alzheimer disease Ann. Neurol. 74, 517-526 (2013).
45. Brender, J. R. et al. Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. Biophys. J. 100, 685-692 (2011).
46. Sciacca, M. F. M. et al. Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. Biophys. J. 104, 173-184 (2013).
47. Lee, C. C., Sun, Y., Huang, H. W. How type II diabetes-related islet amyloid polypeptide damages lipid bilayers. Biophys. J. 102, 1059-1068 (2012).
48. Kontush, A. Amyloid-: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease. Free Radic. Biol. Med. 31, 1120-1131 (2001).
49. Nakamura, M. et al. Three histidine residues of amyloid-peptide control the redox activity of copper and iron. Biochemistry 46, 12737-12743 (2007).
50. Lee, E. C. et al. Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity. Phys. Chem. Chem. Phys. 15, 12558-12571 (2013).
51. Ma, L., Li, X., Wang, Y., Zheng, W. T., Chen, T. Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced beta cell apoptosis through induction of ROS-mediated mitochondrial dysfunction. J. Inorg. Biochem. 140, 143-152 (2014).
52. Lenzen, S. Oxidative stress: the vulnerable-cell. Biochem. Soc. Trans. 36, 343-347 (2008).
53. Zraika, S. et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 52, 626-635 (2009).
54. Cheng, C. et al. Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells. Biomaterials 30, 4152-4160 (2009).
55. Reddy, A. R. N., Krishna, D. R., Himabindu, V., Reddy, Y. N. Single walled carbon nanotubes induce cytotoxicity and oxidative stress in HEK293 cells. Toxicol. Environ. Chem. 96, 931-940 (2014).
56. Shoval, H. et al. Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS. Biochim. Biophys. Acta 1784, 1570-1577 (2008).